Should Polymerase Chain Reaction Analysis to Detect Minimal Residual Disease in Patients With Chronic Myelogenous Leukemia Be Used in Clinical Decision Making?

This publication has 39 references indexed in Scilit:

• The clinical significance of detection of residual disease in childhood ALL
  Critical Reviews in Oncology/Hematology, 1998
• Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity.
  Journal of Clinical Oncology, 1998
• Variable numbers of BCR‐ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon‐α
  British Journal of Haematology, 1995
• Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy
  Annals of Internal Medicine, 1995
• Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.
  Journal of Clinical Investigation, 1994
• Animal Models of BCR/ABL-Induced Leukemias
  Leukemia & Lymphoma, 1993
• The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias
  New England Journal of Medicine, 1988
• Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase
  Annals of Internal Medicine, 1988
• In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.
  Proceedings of the National Academy of Sciences, 1987
• Disappearance of pH¹-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin
  New England Journal of Medicine, 1979